A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
September 2014 CANCER DISCOVERY | 985 rEsEarch Watch Major finding: TARBP2 binding to sRSEs within metastasis suppressor transcripts promotes their decay. Mechanism: TARBP2-driven breast cancer metastasis requires destabilization of the APP and ZNF395 transcripts. impact: Noncanonical pathways of post-transcriptional control can contribute to cancer progression. Yuan B, Cheng L, Chiang HC, Xu X, Han Y, Su H, et al. A phosphotyrosine switch determines the antitumor activity of ERβ.doi:10.1158/2159-8290.cd-rw2014-149 fatcat:tde3hub2ifclveszfs7ycptjsy